23andme glp 1 GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Unlocking the Genetics of GLP-1

While various medications have been known to cause muscle aches, Glucagon-like peptide 1 (GLP-1) agonists have not been commonly associated with this side effect in medical literature.GLP-1 agonists, such as tirzepatide and semaglutide, are highly effective in promoting weight loss

The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions.

This guideline presents recommendations for the evaluation and management of patients with gastroparesis

These actions improve glycemic control and support weight loss

We know that GLP-1 medications can be a powerful tool for weight loss, but they can also come with unwanted side effects